that the cell line ReNcell VM is able to act canonically

Curcumin has entered scientific clinical trials at clinical trial level and the phase I only in the last 10-15 years. A section IItudy of diamond citabine, curcumin and celecoxib is due to ready to accept recruit ment at the Tel AviSourasky Gemcitabine Gemzar Medical Center for patients with metastatic colorectal cancer. Why curcumin Curcumin is a part of turmeric, the yellow spice derived from the roots of the plant Curcuma longa. Curcuma longa is just a short-stemmed perennial, which grows to about 100 cm in height. It has circular leaves and square, ovate or round rhizomes. Curcuma longa grows naturally throughout the Indian subcontinent and in warm countries, specially South East Asia. A traditional solution in Ayurvedic medicine and old Indian healing system that dates back over 5,000 Eumycetoma years, turmeric has been used through the ages as an herbal aspirin and herbal cortisone to relieve inflammation and discomfort associated with a fantastic spectral range of autoimmune and infectious diseases. Curcumin, chemically it is referred to as diferuloylmethane, has been the main topic of a huge selection of club lished papers within the last three decades, learning its anti oxidant, anti toxic, anti inflammatory, cancer chemopreventive and perhaps chemotherapeutic prop erties. The pharmacology and putative anti cancer properties of curcumin have been the subject of a few review articles published since 1991, which pre-date a number of clinical reports of curcumin which have been published and completed within the past few years. But these properties do not prove the superiority of the phytochemical over other chemotherapeutic agents that Z-VAD-FMK also induced apoptosis properly in cancer cells. Majority of chemotherapeutic agents, including those iso lated from plants not just stimulate cancer cell apoptosis but also severely damage the normal cells of the host, the effects being particularly severe in case of the immune system. On the con trary, curcumin is a part of our daily food pattern and its use within large quantities from ancient time has proved that it is a safe product. In reality, since curcumin choose ably induces apoptosis in very proliferating cells, death is a lot more pronounced in tumefaction cells than normal people. Report from our laboratory has shown that anticancer dose of curcumin arrests non-malignant cells in G0 phase reversibly but doesn't induce apoptosis in them. Further studies unveiled that this phytochemical shields T cells of chemotherapeutic agent induced apoptosis in addition to the cancer bearer from cancer. The foundation of this differential regulation could be caused by its differential effects on normal and neoplastic cell rounds since deregulation of some aspects of cell cycle regu latory machinery may drive uncontrolled proliferation and therefore neoplastic transformations.